A Phase II Clinical Trial on Neo-adjuvant Pembrolizumab in Patients With pT3b-T4a/b cN0M0 Melanoma.

Clinical trial NCT07448831 · RECRUITING

Trial details

NCT number: NCT07448831
Sponsor: Universitair Ziekenhuis Brussel
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin Cancer)

Start date: 2025-04-17
Primary completion: 2026-06-30
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.